Mr. Ayman Mokhtar is Viatris Regional President for the Middle East, Turkey & Levant Region.
Viatris is the global healthcare company formed in November 2020 through the combination of Mylan
and Upjohn, a legacy division of Pfizer. Viatris empowers people to live healthier at every stage of
life. Viatris portfolio comprises more than 1,400 approved molecules across a wide range of
therapeutic areas, spanning both non-communicable and infectious diseases.
With more than twenty years of experience in the pharmaceutical industry, Mr. Mokhtar is an
executive with a broad international experience having held strategic positions within multinational
companies and lead regional operations covering the Middle East and Africa. His most recent roles
have been Regional Strategy Lead for Africa and the Middle East at Pfizer and General Manager GCC
Countries for Upjohn a division of Pfizer.
Mr. Mokhtar has a passion for improving patient access to medications through innovative
approaches, connecting stakeholders on common goals and driving meaningful partnerships. In his
active external engagement as board member of several trade associations in the Middle East Region,
he strongly advocates for the importance of collective efforts to optimize healthcare services and
healthcare delivery in the Region. He has been able to forge several public private partnerships in
research, awareness, patient access across the region, notably in the UAE.
Mr. Mokhtar holds a bachelor’s degree in Pharmaceutical Sciences from Cairo University in Egypt. He
has completed several business studies and executive programs the latest being “the Advanced
Management Program Global Experience, International Business” at Northwestern University,
Kellogg School of Management.
Mr. Mokhtar lives in the United Arab Emirates with his family.